Cyclo Therapeutics, Inc.
CYTH
$0.7206
$0.00991.39%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 928.00K | 1.12M | 3.00M | 9.25M | 1.80M |
Total Receivables | 187.70K | 83.70K | 71.30K | 122.40K | 303.80K |
Inventory | 236.10K | 241.00K | 242.50K | 254.40K | 209.80K |
Prepaid Expenses | 177.80K | 3.00M | 3.26M | 2.69M | 3.20M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 1.73M | -- | -- | -- | -- |
Total Current Assets | 3.26M | 4.45M | 6.57M | 12.32M | 5.51M |
|
|||||
Total Current Assets | 3.26M | 4.45M | 6.57M | 12.32M | 5.51M |
Net Property, Plant & Equipment | 46.60K | 267.70K | 593.80K | 929.30K | 85.60K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 1.95M | -- | -- | -- | -- |
Total Assets | 5.25M | 4.72M | 7.16M | 13.25M | 5.60M |
|
|||||
Total Accounts Payable | 5.02M | 3.86M | 3.67M | 4.86M | 6.60M |
Total Accrued Expenses | 1.25M | 1.30M | 1.10M | 1.68M | -- |
Short-term Debt | 12.18M | 2.71M | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 20.10K | 273.50K | 647.60K | 1.01M | 18.00K |
Total Finance Division Other Current Liabilities | 246.80K | 1.68M | 1.12M | 918.00K | -- |
Total Other Current Liabilities | 246.80K | 1.68M | 1.12M | 918.00K | -- |
Total Current Liabilities | 18.72M | 9.83M | 6.54M | 8.47M | 6.62M |
|
|||||
Total Current Liabilities | 18.72M | 9.83M | 6.54M | 8.47M | 6.62M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 12.18M | 2.71M | -- | -- | -- |
Capital Leases | 7.10K | 12.40K | 17.50K | 22.50K | 27.30K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 18.73M | 9.84M | 6.55M | 8.49M | 6.65M |
|
|||||
Common Stock & APIC | 89.54M | 89.06M | 88.81M | 88.61M | 77.16M |
Retained Earnings | -103.01M | -94.18M | -88.20M | -83.86M | -78.21M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -13.47M | -5.12M | 610.00K | 4.76M | -1.05M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -13.47M | -5.12M | 610.00K | 4.76M | -1.05M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -13.47M | -5.12M | 610.00K | 4.76M | -1.05M |
|